Alpha IVF Group Bhd (XKLS:0303) Research & Development: RM0.0 Mil (TTM As of Feb. 2026)


XKLS:0303 Alpha IVF Group Bhd XKLS:0303
50 GF Score
Price RM0.25
View Full Analysis

What is Alpha IVF Group Bhd Research & Development?

Alpha IVF Group Bhd XKLS:0303 +2.08% 50 Research & Development is RM0.0 Mil as of Feb. 2026. GuruFocus rates XKLS:0303 with a GF Score™ of 50/100.

Research & Development is the aggregate amount of research and development expenses during the year. Alpha IVF Group Bhd's Research & Development for the three months ended in Feb. 2026 was RM0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was RM0.0 Mil.

Alpha IVF Group Bhd  (XKLS:0303) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Alpha IVF Group Bhd Research & Development Related Terms

Alpha IVF Group Bhd Research & Development Historical Data

* Premium members only.

The historical data trend for Alpha IVF Group Bhd's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha IVF Group Bhd Research & Development Chart

Alpha IVF Group Bhd Annual Data
Trend May20 May21 May22 May23 May24 May25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Alpha IVF Group Bhd Quarterly Data
May20 May21 May22 May23 Oct23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XKLS:0303
50GF Score
Alpha IVF Group Bhd XKLS:0303
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha IVF Group Bhd Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was RM0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of RM0.0 Mil mean?
Alpha IVF Group Bhd (XKLS:0303) has a Research & Development of RM0.0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Alpha IVF Group Bhd and its competitors.
Is Alpha IVF Group Bhd's Research & Development too high?
Alpha IVF Group Bhd's current Research & Development is RM0.0 Mil. Overall, Alpha IVF Group Bhd has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Alpha IVF Group Bhd's Research & Development compare to HCA and THC?
Alpha IVF Group Bhd's Research & Development of RM0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Alpha IVF Group Bhd and its competitors. Alpha IVF Group Bhd's current Research & Development is RM0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha IVF Group Bhd stock overvalued right now?
Alpha IVF Group Bhd (XKLS:0303) has a current Research & Development of RM0.0 Mil. The current Research & Development is RM0.0 Mil. Alpha IVF Group Bhd's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Alpha IVF Group Bhd (XKLS:0303), the current Research & Development is RM0.0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha IVF Group Bhd Business Description

Address Jalan PJU 5/22, G01, Ground Floor, Encorp Strand Mall, Kota Damansara, Darul Ehsan, Petaling Jaya, SGR, MYS, 47810
Alpha IVF Group Bhd is a fertility care specialist focusing on assisted reproductive services in Malaysia, Singapore, Indonesia, and China, with the majority of its revenue coming from Malaysia. Assisted reproductive services is a general term that includes all types of fertility treatments and procedures to help people facing difficulties in getting pregnant. The company offers a range of assisted reproductive services such as IVF to assist patients with infertility conditions in achieving clinical pregnancy. It also provides other procedures including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), various diagnostic, testing, and screening procedures, as well as cryopreservation of eggs, sperm, and embryos.
50GF Score

Get the complete analysis for XKLS:0303

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.25
Price